The Actinobacillus pleuropneumoniae hemolysin determinant: unlinked appCA and appBD loci flanked by pseudogenes.

Por Chang, Y F, Young, R, Struck, D K
Publicado em 1991

Differential expression of the cytotoxic and hemolytic activities of the ApxIIA toxin from Actinobacillus pleuropneumoniae.

Por Tu, A H, Hausler, C, Young, R, Struck, D K
Publicado em 1994

Identification and characterization of the Pasteurella haemolytica leukotoxin.

Por Chang, Y F, Young, R, Post, D, Struck, D K
Publicado em 1987

Separable domains define target cell specificities of an RTX hemolysin from Actinobacillus pleuropneumoniae.

Por McWhinney, D R, Chang, Y F, Young, R, Struck, D K
Publicado em 1992

Characterization of a neutralizing monoclonal antibody to Pasteurella haemolytica leukotoxin.

Por Gerbig, D G, Cameron, M R, Struck, D K, Moore, R N
Publicado em 1992

Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18

Por Struck, D., Frank, I., Enders, S., Steinhoff, U., Schmidt, C., Stallmach, A., Liesenfeld, O., Heimesaat, M. M.
Publicado em 2012

Reduced parasitemia observed with erythrocytes containing inositol hexaphosphate.

Por Mintzer, C L, Deloron, P, Rice-Ficht, A, Durica, D, Struck, D K, Roessner, C A, Nicolau, C, Ihler, G M
Publicado em 1988

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds

Por Pironti, A, Sönnerborg, A, Zazzi, M, Kaiser, R, Struck, D, Clotet, B, Vandamme, ÀM, Incardona, F, Lengauer, T, Rosen-Zvi, M, Prosperi, M
Publicado em 2010

HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

Por Theys, K., Vercauteren, J., Snoeck, J., Zazzi, M., Camacho, R. J., Torti, C., Schülter, E., Clotet, B., Sönnerborg, A., De Luca, A., Grossman, Z., Struck, D., Vandamme, A.-M., Abecasis, A. B.
Publicado em 2013